Surgical system and method of use of the same

Information

  • Patent Grant
  • 9833146
  • Patent Number
    9,833,146
  • Date Filed
    Tuesday, April 17, 2012
    12 years ago
  • Date Issued
    Tuesday, December 5, 2017
    6 years ago
Abstract
A surgical system configured for treating tissue is provided. The surgical system includes a laser source and a laser scalpel. The laser scalpel is adapted to couple to the laser source and is operable in two modes of operation, a first mode of operation to analyze tissue of interest and a second mode of operation to treat tissue of interest. The laser scalpel includes a housing having first and second fiber optic cables extending therethrough. Each of the first and second fiber optic cables operable under the first mode of operation to collect information pertaining to at least one optical property of tissue of interest and at least one of the first and second fiber optic cables also operable under the second mode of operation to treat the tissue of interest.
Description
BACKGROUND

Technical Field


The present disclosure relates to a surgical system and method of use of the same. More particularly, the present disclosure relates to a self-optimizing laser surgical system including a laser scalpel that utilizes photon density waves to evaluate tissue of interest and adjust the intensity level output of the laser scalpel to an optimal setting for a specific tissue site.


Description of Related Art


The use of laser surgical systems that employ laser scalpels to treat tissue is well established. In a typical laser scalpel, a laser beam is emitted from the scalpel tip and a small focal spot of concentrated laser light energy cuts tissue by local burning or vaporizing at the focal spot. The scalpel tip itself, typically, does not contact the tissue being cut.


The surgeon relies on experience, judgment and technique to determine an intensity level of a laser beam that is to be applied to tissue of interest to achieve a desired tissue effect. Unfortunately, however, characteristics of tissue are not “static.” That is, characteristics of tissue may differ from patient to patient, and/or site to site within a particular patient. For example, tissue associated with a liver of one patient may have characteristics associated therewith that are different than tissue associated with a liver of a different patient. As a result thereof, it is sometimes difficult for a surgeon to determine an appropriate intensity level of the laser beam to treat tissue. As can be appreciated, the efficacy at which a surgeon can utilize conventional laser surgical system with respect to treating tissue may be compromised and/or diminished by the “dynamic” nature of tissue.


SUMMARY

In view of the foregoing, it may prove advantageous to provide a self-optimizing laser surgical system including a laser scalpel that utilizes photon density wave to evaluate tissue of interest and adjust the intensity level output (and in certain instances a modulated frequency) of the laser scalpel to an optimal setting for a specific tissue site.


Embodiments of the present disclosure are described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. As used herein, the term “distal” refers to the portion that is being described which is further from a user, while the term “proximal” refers to the portion that is being described which is closer to a user.


In accordance with the instant disclosure, as used herein, treating tissue may include, but is not limited to dissecting, coagulating, ablating or cutting tissue.


An aspect of the present disclosure provides a surgical system for treating tissue. The surgical system includes a laser. A laser scalpel may be adapted to couple to the laser source and may be operable in two modes of operation, a first mode of operation to analyze tissue of interest and a second mode of operation to treat tissue of interest. The laser scalpel may include a housing having first and second fiber optic cables extending therethrough. Each of the first and second fiber optic cables may be operable under the first mode of operation to collect information pertaining to at least one optical property of tissue of interest and the second fiber optic cable also operable under the second mode of operation to treat the tissue of interest. The laser scalpel may be a carbon dioxide laser scalpel configured to ablate, coagulate or cut tissue.


A switching mechanism may be disposed on either the laser scalpel or the laser source and may be configured to place the laser scalpel in the first and second modes of operation.


In the first mode of operation the second fiber optic cable emits a modulated signal at a frequency (e.g., a frequency between 50 MHz to 3 GHz) capable of producing resolvable photon density waves to propagate through the tissue of interest and the first fiber optic cable receives information pertaining to the photon density waves. In this instance, the information pertaining to the photon density waves may be utilized to calculate the at least one optical property of tissue of interest. The at least one optical property of tissue of interest may be scattering and/or absorption properties of tissue.


One or more control algorithms may be associated with a microprocessor of the laser source and utilize the scattering and absorption properties of the tissue of interest to determine one of an energy output of the laser scalpel, frequency of the laser scalpel, duration of the laser pulses emitted from the laser scalpel, type of waveform utilized by the laser scalpel and duty cycle of the laser scalpel.


The first and second fiber optic cables may extend to a distal face of the housing and may include respective polished end-faces that are positioned flush with the distal face of the housing and bulged to create a rounded projection to enhance contact with tissue of interest. The first and second fiber optic cables may be positioned in vertical registration with respect to one another and spaced-apart from each other at a distance that ranges from about 7 mm to about 10 mm. The first optical fiber may include a diameter that ranges from about 700 microns to about 1 mm and the second optical fiber includes a diameter that ranges from about 200 microns to about 400 microns.


An aspect of the present disclosure provides a method for treating tissue. A laser surgical system including a laser source and a laser scalpel adapted to couple thereto is provided. The laser scalpel is positioned adjacent tissue of interest. The laser scalpel is activated to function in a first mode of operation to analyze the tissue of interest. The laser scalpel is activated in the second mode of operation to treat the tissue of interest, e.g., cut, coagulate or ablate tissue.


The laser scalpel may be provided with a housing having first and second fiber optic cables extending therethrough. Each of the first and second fiber optic cables may be operable under the first mode of operation to collect information pertaining to at least one optical property of tissue of interest and the second fiber optic cable is also operable under the second mode of operation to treat the tissue of interest. The laser scalpel may be provided with a switching mechanism configured to place the laser scalpel in the first and second modes of operation. The first and second fiber optic cables may extend to a distal face of the housing, wherein the first and second fiber optic cables include respective polished end-faces that are positioned flush with the distal face of the housing and bulged to create a rounded projection to enhance contact with tissue of interest.


A modulated signal may be emitted from the second fiber optic cable at a frequency (e.g., a frequency between 50 MHz to 3 GHz) capable of producing resolvable photon capable of causing photon density waves to propagate through the tissue of interest such that the first fiber optic cable receives information pertaining to the photon density waves.


At least one optical property associated with the tissue of interest may be calculated from the information pertaining to the photon density wave, wherein the at least one optical property of tissue of interest is scattering and absorption properties of tissue of interest.


The laser source may be provided with at least one microprocessor and control algorithm that utilizes the scattering and absorption properties of the tissue of interest to determine one of an energy output of the laser scalpel, frequency of the laser scalpel, duration of the laser pulses emitted from the laser scalpel, type of waveform utilized by the laser scalpel and duty cycle of the laser scalpel.





BRIEF DESCRIPTION OF THE DRAWING

Various embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:



FIG. 1 is a perspective view of a self-optimizing laser surgical system including a laser source and laser scalpel according to an embodiment of the present disclosure; and



FIG. 2 is a perspective view of the laser scalpel depicted in FIG. 1.





DETAILED DESCRIPTION

Detailed embodiments of the present disclosure are disclosed herein; however, the disclosed embodiments are merely examples of the disclosure, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present disclosure in virtually any appropriately detailed structure.


As noted above, characteristics of tissue are dynamic and not static and, as a result thereof, it is sometimes difficult to determine an appropriate intensity level of a laser beam needed to effectively treat tissue of interest. In accordance with the instant disclosure, it has been found that utilizing one or more optical properties associated with tissue of interest allows a user to effectively treat tissue of interest irrespective of the patient and/or type of tissue.


Turning now to FIG. 1, a self-optimizing laser surgical system 2 including a laser source 4 and a laser scalpel 6 configured to treat tissue is illustrated. In accordance with the instant disclosure, laser source 4 is operable in two modes of operation, a first mode of operation to analyze tissue of interest and a second mode of operation to treat tissue of interest. To these ends, laser source 4 may include one or more microprocessors 10 that are in operative communication with one or more modules, e.g., a digital signal processing module 12 (DSP 12), of the laser source 4. Processor 10 receives command signals from DSP 12 and regulates one or more parameters associated with a laser beam, e.g., an intensity level of a laser beam, emitted from the laser scalpel 6. DSP 12 may be in operable communication with a detector 11 that may be in the form of a photon multiplier tube, avalanche photo diode, or photodiode. A laser driver 13 may be utilized to modulate the laser to a desired frequency. A read only memory 14 (ROM 14) may store one or more control algorithms configured to determine absorption and scattering properties of tissue based on information collected from the laser scalpel 6 at a tissue treatment site and transmitted to the DSP 12. The DSP 12 and/or the at least one control algorithm may utilize the scattering and absorption properties of the tissue of interest to determine and/or adjust an intensity level of a laser beam emitted from the laser scalpel, frequency of the laser beam emitted from the laser scalpel, duration of the laser pulses of the laser beam emitted from the laser scalpel, type of waveform utilized by the laser scalpel and duty cycle of the laser scalpel.


A driving circuit 16 (FIG. 1) in operable communication with the processor 10 is provided with the laser source 4 and may include one or more light sources (not explicitly shown) configured to generate light at one or more wavelengths. By way of example, the light sources of the driving circuit 16 may be laser diodes (or other suitable device(s)) that emit light with wavelengths of approximately 500 nm to about 2000 nm. By way of example, the light sources of the driving circuit 16 may be laser diodes (or other suitable device(s)) that emit light with wavelengths of approximately 800 nm to about 810 nm or a CO2 laser at about 1060 nm.


A cable 8 connects the laser source 4 to the laser scalpel 6, and may include one or more fiber optic cables therein (FIGS. 1 and 2). Cable 8 may couple to the laser source 4 and laser scalpel 6 via one or more suitable coupling methods, e.g., via an optical connection 15, such as, for example, a fiber channel connector (FC connector) or a subscriber connector (SC connector) (not explicitly shown coupled to the laser scalpel 6), see FIG. 1. In the illustrated embodiment, cable 8 includes a first fiber optic cable 8a and a second fiber optic cable 8b (FIG. 2). Each of the first and second fiber optic cables 8a, 8b are operable under the first mode of operation to collect information pertaining one or more optical properties of tissue of interest, as described in greater detail below.


Referring to FIG. 2, laser scalpel 6 is illustrated. In the illustrated embodiment, the laser scalpel 6 holds the optics fibers that guide and emits one or more suitable lasers, e.g., a carbon dioxide (CO2) laser including a housing 18 having generally rectangular configuration. Other suitable configurations, however, may be utilized for the housing 18. Housing 18 may be made from any suitable material including, but not limited to metal, plastic, ceramic, surgical steel, etc. Housing 18 includes proximal and distal ends 17 and 19, respectively, and is configured to house the first and second fiber optic cables 8a, 8b therein (FIG. 2).


First fiber optic cable 8a extends through a housing 18 of the laser scalpel 6 and includes a distal tip 3 that is disposed flush with a distal face 20 of the housing 18 (FIG. 2). In some embodiments, distal tip 3 may be polished to facilitate positioning the distal tip 3 flush with the distal face 20. In another embodiment, distal tip 3 may be polished and bulged to create a rounded projection that can enhance contact with tissue. In either of the aforementioned embodiments, positioning the first fiber optic cable 8a flush with the distal face 20 facilitates collecting information, e.g., optical information, pertaining to the tissue of interest. First fiber optic cable 8a may include any suitable diameter. In embodiments, the diameter of the first fiber optic cable may range from about 700 microns to about 1 mm.


First fiber optic cable 8a is operable under the first mode of operation to collect information pertaining to one or more optical properties of tissue of interest. In particular, the first fiber optic cable 8a receives information pertaining to photon density waves (PDW). More particularly, the first fiber optic cable 8a receives resolvable amplitude and phase relationships of the PDW. The information pertaining to the PDW is communicated to the DSP 12 for processing and utilized by the control algorithm to calculate one or more optical properties, e.g., scattering and absorption properties, of tissue of interest. In particular, the control algorithm utilizes the phase of the PDW which is sensitive to the scattering coefficient associated with the tissue of interest, and the amplitude of the PDW which is sensitive to the concentrator of the absorber in the tissue of interest to determine an appropriate intensity level and frequency of the laser output for the second mode of operation. In certain embodiments, the first fiber optic cable 8a may also be operable in the second mode of operation.


Continuing with reference to FIG. 2, second fiber optic cable 8b is illustrated. Second fiber optic cable 8b extends through housing 18 and includes a distal tip 5 that is disposed flush with the distal face 20. In some embodiments, distal tip 5 may be polished to facilitate positioning the distal tip 5 flush with the distal face 20. In another embodiment, distal tip 3 may be polished and bulged to create a rounded projection that can enhance contact with tissue. In the illustrated embodiment, second fiber optic cable 8b is positioned in vertical registration with respect to first fiber optic cable 8a. Other positioning configurations, however, of the first and second fiber optic cables 8a, 8b may be utilized. For example, in certain embodiments, the first and second fiber optic cables 8a, 8b may be positioned in horizontal registration with one another. First and second fiber optic cables may be spaced-apart from one another at any suitable distance. The distance that separates the first and second fiber optic cables 8a, 8b from one another affects a penetration depth of the PDW through tissue. The depth of penetration of the PDW is directly proportional to the distance that separates the first and second fiber optic cables 8a, 8b, i.e., the greater the distance, the greater the penetration depth of the PDW through tissue. In one particular embodiment, for example, first and second fiber optic cables 8a and 8b may be spaced-apart from each other at a distance that ranges from about 7 mm to about 10 mm. It has been found that this range is sufficient for analyzing a top layer of tissue of interest.


Second fiber optic cable 8b is operable under the first mode of operation. In particular, second fiber optic cable 8b emits a modulated signal provided by one or more modules or components, e.g., the light source and a modulator (not explicitly shown), of the laser source 4 at a frequency capable of producing distinguishable PDW to propagate through the tissue of interest. It has been found that a modulated signal having a frequency that ranges from about 50 MHz to about 3 GHz is capable of producing distinguishable PDW to propagate through the tissue of interest with meaningful phase and amplitude information.


Unlike first fiber optic cable 8a, however, second fiber optic cable 8b is also operable under the second mode of operation to treat the tissue of interest. To this end, second fiber optic cable 8b includes a diameter that is less than the diameter of the first fiber optic cable to provide a small focal “spot” of concentrated energy at the tissue site. In embodiments, the second fiber optic cable 8b may include a diameter that ranges from about 200 microns to about 400 microns. It has been found that fiber optic cables having diameters close to the 400 micron range can provide laser beams with intensity levels of up to 20 watts, which is suitable to treat tissue of interest in accordance with the instant disclosure.


With reference again to FIG. 2, one or more switching mechanisms 22 may be provided on the laser source 4 and/or laser scalpel 6 and utilized to place the laser scalpel 6 in the first and second modes of operation. In the illustrated embodiment, the switching mechanism 22 is provided on an exterior surface of the housing 18 of the laser scalpel 6. The switching mechanism 22 may be any suitable type of switching mechanism. In some embodiments, such as the illustrated embodiment, the switching mechanism 22 may be an analog push-button switch 24 (FIG. 2). The analog push-button switch 24 is configured to communicate with the microprocessor 10 to place the laser scalpel 6 in the first and second modes of operation.


One or more visual indicators 26 may be provided on the laser scalpel 6 and/or laser source 4 to indicate to a user that the laser scalpel 6 is ready for operation in one of the first and second modes of operation (FIG. 1). For example, one or more light emitting diodes (LEDs) or the like may be provided on the laser source 4 and configured to illuminate when the laser scalpel 6 is ready to operate in one of the first and second modes of operation. Alternatively, or in combination therewith, one or more speakers 28 (FIG. 1) may be provided on the laser source 4 and/or laser scalpel 6 and configured to provide a beep or tone of suitable frequency when the laser scalpel 6 is ready to operate in the first and second modes of operation.


In certain embodiments, the switching mechanism 22 may be configured to illuminate in one or more colors that indicate a specific mode of operation of the laser scalpel 6, e.g., whether the laser scalpel 6 is in the first or second mode of operation.


In operation of one particular embodiment, a user may position the distal face 20 of the laser scalpel 6 adjacent tissue of interest, e.g., flush against tissue of interest. Thereafter, a user may press the push-button switch 24 to place the laser scalpel 6 in the first mode of operation to initiate an optical property analysis of the tissue of interest, e.g., a top layer of the tissue of interest. In one particular embodiment, the push-button 24 stays illuminated in a first color, e.g., red, during the first mode of operation.


In the first mode of operation, laser source 4 transmits a modulated signal that is emitted from the second fiber optic cable 8b to cause resolvable PDW to propagate through the tissue of interest. Moreover, the first fiber optic cable 8a receives the pertinent information relating to tissue of interest, e.g., resolvable amplitude and phase relationships of the PDW, and communicates this information to the DSP 12 to be implemented by the control algorithm.


Thereafter, a control signal is transmitted from the DSP 12 to the microprocessor 10, which, in turn, sets (or in certain instances adjusts) one or more of the aforementioned parameters associated with the laser scalpel 6, e.g., an intensity level of the laser beam emitted from the laser scalpel 6, to an appropriate level.


Subsequently, one or more of the aforementioned indicators, e.g., visual indicators 26, may be automatically activated (e.g., by the microprocessor) to indicate to a user that the optical analysis of tissue of interest is complete and the laser scalpel 6 is ready to operate in the second mode of operation. A user may then press push-button 24 to begin treatment of tissue of interest. In one particular embodiment, the push-button 24 stays illuminated in a second color, e.g., blue, during the first mode of operation.


The self-optimizing laser surgical system 2 overcomes the drawbacks that are typically associated with conventional laser surgical systems. In particular, the self-optimizing laser surgical system 2 provides a user with an efficient method for treating tissue of interest irrespective of the patient and/or type of tissue. That is, self-optimizing laser surgical system 2 adjusts one or more of the aforementioned characteristics of the laser beam based on the scattering and absorption properties of tissue to treat tissue.


From the foregoing and with reference to the various figure drawings, those skilled in the art will appreciate that certain modifications can also be made to the present disclosure without departing from the scope of the same. For example, a footswitch (not explicitly shown) may be provided in addition to or instead of the push-button 24 to control the laser scalpel 6.


One or more monitors 30 (FIG. 1) may be provided on the laser source 4 and configured to provide relevant information pertaining to the laser source 4 and/or laser scalpel 6. The relevant information may include power intensity of the laser beam emitted from second fiber optic cable 8b, duration of duty cycle of laser scalpel 6, etc.


In certain embodiments, a third fiber optic cable 8c may be provided and configured to function as one or both of the first and second fiber optic cables 8a, 8b. For example, and in one particular embodiment, during the first mode of operation, the third fiber optic cable 8c may be configured to receive resolvable amplitude and phase relationships of the PDW. Or, during the first mode of operation, the third fiber optic cable 8c may be configured to emit a modulated signal to produce resolvable PDW to propagate through tissue of interest.


In some embodiments, it may prove advantageous for both the first and second fiber optic cables 8a, 8b to treat tissue. For example, and in one particular embodiment, the first fiber optic cable 8a may be configured to treat tissue with a first laser beam having a particular intensity, waveform, duty cycle, etc., and the second fiber optic cable may be configured to treat tissue with a second laser beam having a particular intensity, waveform, duty cycle, etc. that is different from the first laser beam. This embodiment may prove advantageous in the instance where multiple tissue of interest needs to be treated.


In certain embodiments, it may prove advantageous to provide a laser scalpel 6 with a single fiber optic cable, e.g., second fiber optic cable 8b, that is configured to both analyze and treat tissue of interest. In this particular embodiment, the second fiber optic cable 8b, for example, emits a modulated signal into the tissue of interest and detects a phase shifted return signal therefrom that contains the pertinent information relating to the PDW. Thereafter, the second fiber optic cable 8b emits the laser beam to treat tissue of interest. As can be appreciated, one or more modules and/or components, e.g., a DSP 12 having phase delay capabilities, may be added to the laser source 4 to accommodate for this specific configuration of the fiber optic cable 8b.


Additionally, while the laser surgical system 2 has been described as utilizing a laser scalpel 6 that utilizes CO2 gas, other embodiments may include a laser scalpel 6 that utilizes Helium-Neon (HeNe) gas or Argon (Ar) gas. Moreover, other embodiments may include a laser scalpel 6 that utilizes a combination of one or more suitable metals, solid state and gases, such as, for example, Neodymium-doped Yttrium Aluminium Garnet (Nd:YAG), Helium-Silver (HeAg) and Neon-Copper (NeCu).


Further, while laser scalpel 6 has been described as a “gas” type laser, other embodiments may include laser scalpels 6 that are chemical lasers, solid state lasers, photonic lasers, semiconductor lasers, dye lasers, bio lasers, etc.


While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims
  • 1. A surgical system for treating tissue, comprising: a laser source;a laser scalpel adapted to couple to the laser source and operable in a first mode of operation to analyze tissue and a second mode of operation to treat the tissue, the laser scalpel including a housing, the housing defining a longitudinal axis and including: a first pair of opposing planar surfaces defining a length of the housing;a second pair of opposing planar surfaces separating the first pair of opposing planar surfaces, the second pair of opposing planar surfaces defining a thickness of the housing;a switch in communication with the laser source and extending from one of the first pair of opposing planar surfaces, the switch configured to be pressed relative to the housing to selectively place the laser scalpel in one of the first or second mode of operation;a planar first distal face;a planar second distal face configured to contact the tissue; anda chamfered third distal face extending proximally from a first linear edge of the first distal planar face to a distal end of one of the first pair of opposing planar surfaces, the second distal face extending proximally from a second linear edge of the first distal face to a distal end of the other of the first pair of opposing planar surfaces and disposed at an oblique angle relative to the longitudinal axis defined by the housing, each of the first, second, and third distal faces disposed between the first pair of opposing planar surfaces; andfirst and second fiber optic cables extending through the housing to the planar second distal face and each of the first and second fiber optic cables including a distal tip bulged from the planar second distal face to create a rounded projection extending from the planar second distal face, each of the first and second fiber optic cables operable in the first mode of operation to collect information pertaining to at least one optical property of tissue, and at least one of the first or second fiber optic cables also operable in the second mode of operation to treat tissue, the first fiber optic cable configured to receive amplitude and phase information of a resolvable photon density wave generated through tissue by the second fiber optic cable during the first mode of operation, the laser source including a processor configured to: utilize the amplitude information to determine a concentrator of an absorber in the tissue;utilize the phase information to determine a scattering coefficient of the tissue; andcontrol an intensity level and frequency of a laser beam emitted from the laser scalpel during the second mode of operation based on the determined concentrator of the absorber in the tissue and the determined scattering coefficient of the tissue,wherein the first and second fiber optic cables are positioned in vertical registration with respect to one another and spaced-apart from one another at a distance that ranges from about 7 mm to about 10 mm.
  • 2. A surgical system according to claim 1, wherein in the first mode of operation, the second fiber optic cable emits a modulated signal at a frequency capable of producing resolvable photon density waves to propagate through the tissue and the first fiber optic cable receives information pertaining to the photon density waves, and in the second mode of operation the second fiber optic cable is operable to treat the tissue.
  • 3. A surgical system according to claim 1, wherein the first optical fiber includes a diameter that ranges from about 700 microns to about 1 mm and the second optical fiber includes a diameter that ranges from about 200 microns to about 400 microns.
  • 4. A surgical system according to claim 1, wherein the laser scalpel is a carbon dioxide laser scalpel.
  • 5. A surgical system according to claim 1, wherein at least one of the first or second fiber optic cables are operable to one of ablate or coagulate the tissue when the laser scalpel is in the second mode of operation.
  • 6. A surgical system according to claim 1, further comprising a third fiber optic cable extending through the housing to the planar second distal face of the housing and including a distal tip bulged from the planar second distal face of the housing to create a rounded projection extending from the planar second distal face.
  • 7. A surgical system according to claim 6, wherein the third fiber optic cable is configured to function as one or both of the first and second fiber optic cables and configured receive resolvable amplitude and phase relationships of photon density waves.
  • 8. A surgical system for treating tissue, comprising: a laser source;a laser scalpel adapted to couple to the laser source and operable in a first mode of operation to analyze tissue and a second mode of operation to treat the tissue, the laser scalpel including a housing, the housing defining a longitudinal axis and including: a first pair of opposing planar surfaces defining a length of the housing;a second pair of opposing planar surfaces separating the first pair of opposing planar surfaces, the second pair of opposing planar surfaces defining a thickness of the housing;a push-button switch in communication with the laser source and extending from one of the first pair of opposing planar surfaces, the push-button switch configured to be pressed relative to the housing to selectively place the laser scalpel in one of the first or second mode of operation;a planar first distal face;a planar second distal face configured to contact the tissue; anda chamfered third distal face extending proximally from a first linear edge of the first distal planar face to a distal end of one of the first pair of opposing planar surfaces, the second distal face extending proximally at an oblique angle relative to the longitudinal axis from a second linear edge of the first distal face to a distal end of the other of the first pair of opposing planar surfaces; andfirst and second fiber optic cables extending through the housing to the planar second distal face, each of the first and second fiber optic cables operable in the first mode of operation to collect information pertaining to at least one optical property of tissue, and at least one of the first or second fiber optic cables also operable in the second mode of operation to treat tissue.
US Referenced Citations (224)
Number Name Date Kind
3638640 Shaw Feb 1972 A
4223680 Jöbsis Sep 1980 A
4281645 Jöbsis Aug 1981 A
4321930 Jöbsis et al. Mar 1982 A
4589404 Barath May 1986 A
4682594 Mok Jul 1987 A
4714341 Hamaguri et al. Dec 1987 A
4805623 Jöbsis Feb 1989 A
4807631 Hersh et al. Feb 1989 A
4911167 Corenman et al. Mar 1990 A
4913150 Cheung et al. Apr 1990 A
4936679 Mersch Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4971062 Hasebe et al. Nov 1990 A
4972331 Chance Nov 1990 A
4974591 Awazu et al. Dec 1990 A
5028787 Rosenthal et al. Jul 1991 A
5065749 Hasebe et al. Nov 1991 A
5084327 Stengel Jan 1992 A
5088493 Giannini et al. Feb 1992 A
5119815 Chance Jun 1992 A
5122974 Chance Jun 1992 A
5167230 Chance Dec 1992 A
5190038 Polson et al. Mar 1993 A
5246003 DeLonzor Sep 1993 A
5247931 Norwood Sep 1993 A
5263244 Centa et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5279295 Martens et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5355880 Thomas et al. Oct 1994 A
5372136 Steuer et al. Dec 1994 A
5385143 Aoyagi Jan 1995 A
5390670 Centa et al. Feb 1995 A
5413099 Schmidt et al. May 1995 A
5451220 Ciervo Sep 1995 A
5469845 DeLonzor et al. Nov 1995 A
5482036 Diab et al. Jan 1996 A
5483646 Uchikoga Jan 1996 A
5495541 Murray Feb 1996 A
5497769 Gratton et al. Mar 1996 A
5553614 Chance Sep 1996 A
5555885 Chance Sep 1996 A
5564417 Chance Oct 1996 A
5575285 Takanashi et al. Nov 1996 A
5611337 Bukta Mar 1997 A
5630413 Thomas et al. May 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5653706 Zavislan et al. Aug 1997 A
5680857 Pelikan et al. Oct 1997 A
5692503 Keunstner Dec 1997 A
5730124 Yamauchi Mar 1998 A
5758644 Diab et al. Jun 1998 A
5779631 Chance Jul 1998 A
5782757 Diab et al. Jul 1998 A
5785703 Goodman et al. Jul 1998 A
5786592 Hök Jul 1998 A
5830136 DeLonzor et al. Nov 1998 A
5830139 Abreu Nov 1998 A
5831598 Kauffert et al. Nov 1998 A
5842981 Larsen et al. Dec 1998 A
5871442 Madarasz et al. Feb 1999 A
5873821 Chance et al. Feb 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5995855 Kiani et al. Nov 1999 A
5995856 Mannheimer et al. Nov 1999 A
5995859 Takahashi Nov 1999 A
6011986 Diab et al. Jan 2000 A
6064898 Aldrich May 2000 A
6081742 Amano et al. Jun 2000 A
6088607 Diab et al. Jul 2000 A
6120460 Abreu Sep 2000 A
6134460 Chance Oct 2000 A
6150951 Olejniczak Nov 2000 A
6154667 Miura et al. Nov 2000 A
6163715 Larsen et al. Dec 2000 A
6181958 Steuer et al. Jan 2001 B1
6181959 Schöllermann et al. Jan 2001 B1
6192260 Chance Feb 2001 B1
6192261 Gratton et al. Feb 2001 B1
6230035 Aoyagi et al. May 2001 B1
6266546 Steuer et al. Jul 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6312393 Abreu Nov 2001 B1
6322515 Goor et al. Nov 2001 B1
6352502 Chaiken et al. Mar 2002 B1
6353750 Kimura et al. Mar 2002 B1
6397091 Diab et al. May 2002 B2
6415236 Kobayashi et al. Jul 2002 B2
6419671 Lemberg Jul 2002 B1
6438399 Kurth Aug 2002 B1
6461305 Schnall Oct 2002 B1
6466809 Riley Oct 2002 B1
6487439 Skladnev et al. Nov 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6516209 Cheng et al. Feb 2003 B2
6526301 Larsen et al. Feb 2003 B2
6544193 Abreu Apr 2003 B2
6546267 Sugiura et al. Apr 2003 B1
6549795 Chance Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6591122 Schmitt Jul 2003 B2
6594513 Jöbsis et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6606511 Ali et al. Aug 2003 B1
6615064 Aldrich Sep 2003 B1
6618042 Powell Sep 2003 B1
6622095 Kobayashi et al. Sep 2003 B2
6654621 Palatnik et al. Nov 2003 B2
6654624 Diab et al. Nov 2003 B2
6658276 Kianl et al. Dec 2003 B2
6658277 Wasserman Dec 2003 B2
6662030 Khalil et al. Dec 2003 B2
6668183 Hicks et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671528 Steuer et al. Dec 2003 B2
6675029 Monfre et al. Jan 2004 B2
6678543 Diab et al. Jan 2004 B2
6681128 Steuer et al. Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6687519 Steuer et al. Feb 2004 B2
6690958 Walker et al. Feb 2004 B1
6697658 Al/Ali Feb 2004 B2
6708048 Chance Mar 2004 B1
6711424 Fine et al. Mar 2004 B1
6711425 Reuss Mar 2004 B1
6714245 Ono Mar 2004 B1
6731274 Powell May 2004 B2
6785568 Chance Aug 2004 B2
6793654 Lemberg Sep 2004 B2
6801648 Cheng Oct 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801798 Geddes et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6829496 Nagai et al. Dec 2004 B2
6850053 Daalmans et al. Feb 2005 B2
6859658 Krug Feb 2005 B1
6863652 Huang et al. Mar 2005 B2
6873865 Steuer et al. Mar 2005 B2
6889153 Dietiker May 2005 B2
6898451 Wuori May 2005 B2
6939307 Dunlop Sep 2005 B1
6947780 Scharf Sep 2005 B2
6949081 Chance Sep 2005 B1
6961598 Diab Nov 2005 B2
6983178 Fine et al. Jan 2006 B2
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
7006676 Zeylikovich et al. Feb 2006 B1
7024235 Melker et al. Apr 2006 B2
7027849 Al/Ali Apr 2006 B2
7027850 Wasserman Apr 2006 B2
7030749 Al/Ali Apr 2006 B2
7035697 Brown Apr 2006 B1
7041063 Abreu May 2006 B2
7043289 Fine et al. May 2006 B2
7047056 Hannula et al. May 2006 B2
7060035 Wasserman Jun 2006 B2
7065392 Kato Jun 2006 B2
7090648 Sackner et al. Aug 2006 B2
7095491 Forstner et al. Aug 2006 B2
7127278 Melker et al. Oct 2006 B2
7130672 Pewzner et al. Oct 2006 B2
7162306 Caby et al. Jan 2007 B2
7164938 Geddes et al. Jan 2007 B2
7209775 Bae et al. Apr 2007 B2
7225005 Kaufman et al. May 2007 B2
7236811 Schmitt Jun 2007 B2
7236813 Parker Jun 2007 B2
7239902 Schmitt et al. Jul 2007 B2
7251518 Herrmann Jul 2007 B2
7257433 Takamura et al. Aug 2007 B2
7263395 Chan et al. Aug 2007 B2
7272426 Schmid Sep 2007 B2
7277741 Debreczeny et al. Oct 2007 B2
7330746 Demuth et al. Feb 2008 B2
7343186 Lamego et al. Mar 2008 B2
7373193 Al/Ali et al. May 2008 B2
7375347 Colvin et al. May 2008 B2
7378954 Wendt May 2008 B2
7469158 Cutler et al. Dec 2008 B2
7548771 Mannheimer Jun 2009 B2
7551950 Cheng Jun 2009 B2
7621877 Schnall Nov 2009 B2
7689259 Mannheimer et al. Mar 2010 B2
7904139 Chance Mar 2011 B2
7979102 Hannula et al. Jul 2011 B2
8046059 Cho et al. Oct 2011 B2
8078246 Mannheimer et al. Dec 2011 B2
8082015 Yodh et al. Dec 2011 B2
8108022 Balberg et al. Jan 2012 B2
8126524 Balberg et al. Feb 2012 B2
8229529 Schmitt Jul 2012 B2
8255029 Addison et al. Aug 2012 B2
20020042558 Mendelson Apr 2002 A1
20020156354 Larson Oct 2002 A1
20020198443 Ting Dec 2002 A1
20030023140 Chance Jan 2003 A1
20040039379 Viator et al. Feb 2004 A1
20040162548 Reiser Aug 2004 A1
20050113651 Wood et al. May 2005 A1
20050113656 Chance May 2005 A1
20050177034 Beaumont Aug 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050209516 Fraden Sep 2005 A1
20050228248 Dietiker Oct 2005 A1
20050267346 Faber et al. Dec 2005 A1
20060052680 Diab Mar 2006 A1
20060052709 DeBaryshe et al. Mar 2006 A1
20060129038 Zelenchuk et al. Jun 2006 A1
20060247501 Ali Nov 2006 A1
20070093702 Yu et al. Apr 2007 A1
20080139908 Kurth Jun 2008 A1
20080312533 Balberg et al. Dec 2008 A1
20090281536 Beckman et al. Nov 2009 A1
20090287197 Hanley et al. Nov 2009 A1
20100081899 McKenna Apr 2010 A1
20110071373 Li Mar 2011 A1
20110077485 Baker Mar 2011 A1
20110082526 Rizoiu et al. Apr 2011 A1
20110160713 Neuberger Jun 2011 A1
20130030267 Lisogurski et al. Jan 2013 A1
Foreign Referenced Citations (44)
Number Date Country
732799 May 2001 AU
69123448 May 1997 DE
19640807 Sep 1997 DE
0194105 Sep 1986 EP
3124073 May 1991 JP
3170866 Jul 1991 JP
3238813 Oct 1991 JP
4191642 Jul 1992 JP
4332536 Nov 1992 JP
5049624 Mar 1993 JP
7124138 May 1995 JP
10216115 Sep 1998 JP
11019074 Jan 1999 JP
2003194714 Jul 2003 JP
2003210438 Jul 2003 JP
2003275192 Sep 2003 JP
2003339678 Dec 2003 JP
2004008572 Jan 2004 JP
2004194908 Jul 2004 JP
2004202190 Jul 2004 JP
2004248819 Sep 2004 JP
2004290544 Oct 2004 JP
2004290545 Oct 2004 JP
WO 9101678 Feb 1991 WO
WO 9200513 Jan 1992 WO
WO 9221281 Dec 1992 WO
WO 9309711 May 1993 WO
WO 9313706 Jul 1993 WO
WO 9316629 Sep 1993 WO
WO 9403102 Feb 1994 WO
WO 9512349 May 1995 WO
WO 9749330 Dec 1997 WO
WO 9817174 May 1998 WO
WO 9842249 Oct 1998 WO
WO 9842251 Oct 1998 WO
WO 9843071 Oct 1998 WO
WO 9932030 Jul 1999 WO
WO 0021438 Apr 2000 WO
WO 0140776 Jun 2001 WO
WO 03077750 Sep 2003 WO
WO 2004010844 Feb 2004 WO
WO 2005009221 Feb 2005 WO
WO 2005064314 Jul 2005 WO
WO 2007051066 May 2007 WO
Related Publications (1)
Number Date Country
20130274727 A1 Oct 2013 US